The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
(Approval lapsed) MOUNJARO KWIKPEN tirzepatide 5mg solution for injection in pre-filled pen (UK)
Section 19A approved medicine
(Approval lapsed) MOUNJARO KWIKPEN tirzepatide 5mg solution for injection in pre-filled pen (UK)
Section 19A approval holder
Eli Lilly Australia Pty Ltd ABN 39 000 233 992
Phone
1800 454 559
Approved until
Status
Expired
Medicines in short supply/unavailable
MOUNJARO tirzepatide 5 mg/0.5 mL solution for injection vial - ARTG 407050
Indication(s)
MOUNJARO is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:
- as monotherapy when metformin is not tolerated or contraindicated.
- in addition to other medicinal products for the treatment of type 2 diabetes.
Images
